Pure Global
NCT04651998

Effect of Carotid Artery Stent on Evoked Cerebral Blood Oxygenation and Neurocognitive Functioning

Shanghai Jiao Tong University Affiliated Sixth People's Hospital·ClinicalTrials.gov·diagnostic testRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carotid Artery Stenosis
Drug/Device/Intervention
MMSE, MoCA, functional near-infrared spectroscopy
Study type
Observational
Intervention type
diagnostic test
Sponsor & location
Primary sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Location
Shanghai, China
Timeline & enrollment
Phase
N/A
Start date
May 01, 2021
End date
Dec 30, 2022
Enrollment
74 participants
Primary outcome

Change of cognitive function score

Summary

Cerebral hemodynamic compromise from internal carotid artery stenosis may be a cause of
 vascular cognitive impairment that is amenable to treatment by revascularization. The effect
 of carotid artery stent on evoked cerebral blood oxygenation and neurocognitive functioning
 will be evaluated by functional near-infrared spectroscopy. Carotid artery stent could
 benefit cerebral blood oxygenation after stent and improving neurocognitive functioning after
 6 months.

ICD-10 classifications
Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT04651998
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT04651998 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanghai Jiao Tong University Affiliated Sixth People's Hospital and is currently Recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 74 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.